Erratum to: Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network

Erratum to: Breast Cancer Res Treat DOI 10.1007/s10549-010-0893-0

Authors regret to inform that, due to an unfortunate oversight, some data from the Swiss breast screening programme was omitted. The second and third sentences of the second paragraph of the Results should read.

Of the 29 countries approached, 8 programs recorded the use of prescribed HT at each screening episode (Table 1). Five of the eight also sought information about ever use of HT with four of the five, and one other, recording whether combined HT or progestin alone was prescribed.

The corrected Tables 1 and 2 are given as follows.

Table 1 Self-reported information on hormone therapy use in breast cancer screening programs: results from the International Cancer Screening Network

Table 2 Recording of mammographic breast density (BD) in breast cancer screening programs: results from the International Cancer Screening Network